147 related articles for article (PubMed ID: 6216715)
1. Circulating immune complexes and complement in the course of multiple sclerosis.
Jans H; Heltberg A; Raun NE
Acta Neurol Scand; 1982 Oct; 66(4):488-96. PubMed ID: 6216715
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes in retinitis pigmentosa.
Heredia CD; Huguet J; Cols N; Engel P; García-Calderón PA
Br J Ophthalmol; 1984 Nov; 68(11):811-4. PubMed ID: 6333894
[TBL] [Abstract][Full Text] [Related]
4. Changes of serum complement and of circulating immune complexes in patients with multiple sclerosis.
Cojocaru M; Serbănescu A; Cojocaru IM
Rom J Intern Med; 1993; 31(2):131-7. PubMed ID: 8268831
[TBL] [Abstract][Full Text] [Related]
5. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in healthy persons.
Jans H; Dybkjaer E; Halberg P
Scand J Rheumatol; 1982; 11(4):194-8. PubMed ID: 7178855
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
8. Bell's palsy: an immune complex disease.
Larsson A; Jonsson L; Sjöquist J
ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
[TBL] [Abstract][Full Text] [Related]
9. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
10. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes and complement levels in hemophilic children.
Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
[TBL] [Abstract][Full Text] [Related]
12. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY
Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
[TBL] [Abstract][Full Text] [Related]
13. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis.
Makni S; Ayed K; Ben Said M; Ben Rachid MS
Ann Trop Med Parasitol; 1989 Aug; 83(4):349-55. PubMed ID: 2532497
[TBL] [Abstract][Full Text] [Related]
14. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in Indian childhood cirrhosis.
Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
[TBL] [Abstract][Full Text] [Related]
16. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
[TBL] [Abstract][Full Text] [Related]
17. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes in retinitis pigmentosa.
García-Calderón PA; Engel P; Cols N; Heredia García CD
Ophthalmic Paediatr Genet; 1984 Dec; 4(3):199-202. PubMed ID: 6545398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]